Piper Sandler Initiates Coverage on Equillium With Overweight Rating, $20 Price Target
Equillium (EQ) has an average rating of buy and mean price target of $7.12, according to analysts polled by FactSet.
7 stories mentioning EQUpdated 72d ago
Every FINWIRES story that references EQ, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
Equillium (EQ) has an average rating of buy and mean price target of $7.12, according to analysts polled by FactSet.
Stephen Connelly, President and Chief Scientific Officer, on June 04, 2026, sold 230,975 shares in Equillium (EQ) for $723,830. Following the Form 4 filing with the SEC, Connelly has control over a total of 762,025 common shares of the company, with 762,025 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1746466/000174680826000004/xslF345X05/form4-06052026_080654.xml
Christine Zedelmayer, Senior Vice President and Chief Operating Officer, on May 27, 2026, sold 95,833 shares in Equillium (EQ) for $267,209. Following the Form 4 filing with the SEC, Zedelmayer has control over a total of 62,586 common shares of the company, with 62,586 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1746466/000179781826000009/xslF345X05/form4-05292026_100515.xml
Equillium (EQ) has an average rating of buy and mean price target of $7.12, according to analysts polled by FactSet.
Equillium (EQ) has an average rating of Buy and mean price target of $6.71, according to analysts polled by FactSet.
Equillium (EQ) has an average rating of buy and mean price target of $6.80, according to analysts polled by FactSet.
Equillium (EQ) has an average rating of buy and mean price target of $6.80, according to analysts polled by FactSet.